Journal
HISTOPATHOLOGY
Volume 76, Issue 5, Pages 638-639Publisher
WILEY
DOI: 10.1111/his.14038
Keywords
urinary bladder; nested variant urothelial carcinoma; molecular classification; differential diagnosis; TERT promoter mutation; FGFR3 mutation; targeted therapy